Mitomycin c and the Endoscopic treatment of laryngotracheal stenosis: Are two applications better than one?

Laryngoscope

Volumn 119, Issue 2, 2009, Pages 272-283

  Smith, Marshall E ^a   Elstad, Mark ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Airway; Bronchoscopy; Dilation; Laryngotracheal stenosis; Mitomycin

Indexed keywords

MITOMYCIN C; PLACEBO; ALKYLATING AGENT; MITOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARBON DIOXIDE LASER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; ENDOSCOPIC THERAPY; FEMALE; HUMAN; LARYNGOTRACHEAL STENOSIS; LARYNX STENOSIS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SUBGLOTTIC STENOSIS; TRACHEA STENOSIS; WEGENER GRANULOMATOSIS; WOUND HEALING; LARYNGOSCOPY; LOW LEVEL LASER THERAPY; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; RECURRENT DISEASE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ALKYLATING AGENTS; CHILD; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LARYNGOSCOPY; LARYNGOSTENOSIS; LASER THERAPY; MALE; MIDDLE AGED; MITOMYCIN; PLACEBOS; PROSPECTIVE STUDIES; RECURRENCE; TRACHEAL STENOSIS; TREATMENT OUTCOME;

EID: 63249132655     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20056     Document Type: Article

References (50)

1. Goldenberg D., Esclamado R., Flint P., Cummings CW. Surgical management of upper airway stenosis. In: Cummings CW, Flint PW, Harker LA, Haughey BH, Richardson MA, Robbins KT, Schuller DE, Thomas JR, eds. Cummings Otolaryngology Head & Neck Surgery. Philadelphia, PA: Elsevier Mosby; 2005:2103-2127.
2. Simpson GT, Strong MS, Healy GB, Shapshay SM, Vaughan CW. Predictive factors of success or failure in the endoscopic management of laryngeal and tracheal stenosis. Ann Otol Rhinol Laryngol 1982; 91:384-388.
3. Duncavage JA, Ossoff RH, Toohill RJ. Carbon dioxide laser management of laryngeal stenosis. Ann Otol Rhinol Laryngol 1985; 94:565-569.
4. Ossoff RH, Tucker GF Jr, Duncavage JA, Toohill RJ. Efficacy of bronchoscopic carbon dioxide laser surgery for benign strictures of the trachea. Laryngoscope 1985; 95: 1220-1223.
5. Supance JS. Antibiotics and steroids in the treatment of acquired subglottic stenosis. A canine model study. Ann Otol Rhinol Laryngol 1983; 92:377-382.
6. Croft CB, Zub K., Borowiecki B. Therapy of iatrogenic subglottic stenosis: a steroid/antibiotic regimen. Laryngoscope 1979; 89:482-489.
7. Healy GB. An experimental model for the endoscopic correction of subglottic stenosis with clinical applications. Laryngoscope 1982; 92:1103-1115.
8. Cobb WB, Sudderth JF. Intralesional steroids in laryngeal stenosis. A preliminary report. Arch Otolaryngol 1972; 96: 52-56.
9. Gnanapragasam A. Intralesional steroids in conservative management of subglottic stenosis of the larynx. Int Surg 1979; 64:63-67.
10. Koufman JA, Thompson JN, Kohut RI. Endoscopic management of subglottic stenosis with the CO2 surgical laser. Otolaryngol Head Neck Surg 1981; 89:215-220.
11. Hoffman GS, Thomas-Golbanov CK, Chan J., Akst LM, Eliachar I. Treatment of subglottic stenosis, due to Wegener's granulomatosis, with intralesional corticosteroids and dilation. J Rheumatol 2003; 30:1017-1021.
12. Campbell BH, Dennison BF, Durkin GE, Strigenz MA, Toohill RJ. Early and late dilatation for acquired subglottic stenosis. Otolaryngol Head Neck Surg 1986; 95: 566-573.
13. Goode RL, Shinn JB. Long-term stenting in the treatment of subglottic stenosis. Ann Otol Rhinol Laryngol 1977; 86: 795-798.
14. Montgomery WW. Chronic subglottic stenosis. Otolaryngol Clin North Am 1984; 17:107-113.
15. Albert DM, Cotton RT, Conn P. Effect of laryngeal stenting in a rabbit model. Ann Otol Rhinol Laryngol 1990; 99: 108-111.
16. Zalzal GH. Stenting for pediatric laryngotracheal stenosis. Ann Otol Rhinol Laryngol 1992; 101:651-655.
17. Senders CW. Use of mitomycin C in the pediatric airway. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 473-475.
18. Ward RF, April MM. Mitomycin-C in the treatment of tracheal cicatrix after tracheal reconstruction. Int J Pediatr Otorhinolaryngol 1998; 44:221-226.
19. Rahbar R., Valdez TA, Shapshay SM. Preliminary results of intraoperative mitomycin-C in the treatment and prevention of glottic and subglottic stenosis. J Voice 2000; 14: 282-286.
20. Hartnick CJ, Hartley BE, Lacy PD, et al. Topical mitomycin application after laryngotracheal reconstruction: a randomized, double-blind, placebo-controlled trial. Arch Otolaryngol Head Neck Surg 2001; 127:1260-1264.
21. Rahbar R., Jones DT, Nuss RC, et al. The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract: friend or foe? Arch Otolaryngol Head Neck Surg 2002; 128:401-406.
22. Rahbar R., Shapshay SM, Healy GB. Mitomycin: effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol 2001; 110:1-6.
23. Valdez TA, Shapshay SM. Idiopathic subglottic stenosis revisited. Ann Otol Rhinol Laryngol 2002; 111:690-695.
24. Perepelitsyn I., Shapshay SM. Endoscopic treatment of laryngeal and tracheal stenosis-has mitomycin C improved the outcome? Otolaryngol Head Neck Surg 2004; 131:16-20.
25. Roh JL, Yoon YH. Prevention of anterior glottic stenosis after transoral microresection of glottic lesions involving the anterior commissure with mitomycin C. Laryngoscope 2005; 115:1055-1059.
26. Schweinfurth JM. Endoscopic treatment of severe tracheal stenosis. Ann Otol Rhinol Laryngol 2006; 115:30-34.
27. Simpson CB, James JC. The efficacy of mitomycin-C in the treatment of laryngotracheal stenosis. Laryngoscope 2006; 116:1923-1925.
28. Koshkareva Y., Gaughan JP, Soliman AM. Risk factors for adult laryngotracheal stenosis: a review of 74 cases. Ann Otol Rhinol Laryngol 2007; 116:206-210.
29. Ferguson B., Gray SD, Thibeault S. Time and dose effects of mitomycin C on extracellular matrix fibroblasts and proteins. Laryngoscope 2005; 115:110-115.
30. Simman R., Alani H., Williams F. Effect of mitomycin C on keloid fibroblasts: an in vitro study. Ann Plast Surg 2003; 50:71-76.
31. Ribeiro Fde A., Guaraldo L., Borges Jde P., Zacchi FF, Eckley CA. Clinical and histological healing of surgical wounds treated with mitomycin C. Laryngoscope 2004; 114:148-152.
32. Porter GT, Gadre SA, Calhoun KH. The effects of intradermal and topical mitomycin C on wound healing. Otolaryngol Head Neck Surg 2006; 135:56-60.
33. Shapshay SM, Beamis JF Jr, Hybels RL, Bohigian RK. Endoscopic treatment of subglottic and tracheal stenosis by radial laser incision and dilation. Ann Otol Rhinol Laryngol 1987; 96:661-664.
34. Ubell ML, Ettema SL, Toohill RJ, Simpson CB, Merati AL. Mitomycin-c application in airway stenosis surgery: analysis of safety and costs. Otolaryngol Head Neck Surg 2006; 134:403-406.
35. Roh JL, Kim DH, Rha KS, Sung MW, Kim KH, Park CI. Benefits and risks of mitomycin use in the traumatized tracheal mucosa. Otolaryngol Head Neck Surg 2007; 136: 459-463.
36. Shvidler J., Bothwell NE, Cable B. Refining indications for the use of mitomycin C using a randomized controlled trial with an animal model. Otolaryngol Head Neck Surg 2007; 136:653-657.
37. Karagiannidis C., Velehorschi V., Obertrifter B., Macha HN, Linder A., Freitag L. High-level expression of matrix-associated transforming growth factor-beta1 in benign airway stenosis. Chest 2006; 129:1298-1304.
38. Dillard DG, Gal AA, Roman-Rodriguez J., White S., Jacobs IN. Transforming growth factor and neutralizing antibodies in subglottic stenosis. Ann Otol Rhinol Laryngol 2001; 110:393-400.
39. Chen T., Kunnavatana SS, Koch RJ. Effects of mitomycin-C on normal dermal fibroblasts. Laryngoscope 2006; 116: 514-517.
40. Cordeiro MF. Beyond Mitomycin: TGF-beta and wound healing. Prog Retin Eye Res 2002; 21:75-89.
41. Ingrams DR, Ashton P., Dhingra J., Shah R., Shapshay SM. Slow-release 5-fluorouracil and triamcinolone reduces subglottic stenosis in a rabbit model. Ann Otol Rhinol Laryngol 2000; 109:422-424.
42. Cincik H., Gungor A., Cakmak A., et al. The effects of mitomycin C and 5-fluorouracil/triamcinolone on fibrosis/scar tissue formation secondary to subglottic trauma (experimental study). Am J Otolaryngol 2005; 26:45-50.
43. Eliashar R., Ochana M., Maly B., Pines M., Sichel JY, Nagler A. Halofuginone prevents subglottic stenosis in a canine model. Ann Otol Rhinol Laryngol 2006; 115:382-386.
44. Ertugrul EE, Cincik H., Dogru S., et al. Effects of halofuginone on fibrosis formation secondary to experimentally induced subglottic trauma. Laryngoscope 2007; 117:299-302.
45. McGaha TL, Phelps RG, Spiera H., Bona C. Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor- beta-mediated Smad3 activation in fibroblasts. J Invest Dermatol 2002; 118:461-470.
46. Elkin M., Miao HQ, Nagler A., et al. Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. Faseb J 2000; 14:2477-2485.
47. Ruffy MB, Kunnavatana SS, Koch RJ. Effects of tamoxifen on normal human dermal fibroblasts. Arch Facial Plast Surg 2006; 8:329-332.
48. Mikulec AA, Hanasono MM, Lum J., Kadleck JM, Kita M., Koch RJ. Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts. Arch Facial Plast Surg 2001; 3:111-114.
49. Kaftan H., Hosemann W. Topical application of mitomycin C before versus after myringotomy: an experimental study. ORL J Otorhinolaryngol Relat Spec 2006; 68:73-76.
50. Lee KH, Ko GY, Song HY, Shim TS, Kim WS. Benign tracheobronchial stenoses: long-term clinical experience with balloon dilation. J Vasc Interv Radiol 2002; 13: 909-914.